In a Spanish study of 492 BRCA1- and BRCA2 tested-negative breast cancer patients with family history of breast and/or ovarian cancer, they identified 12 variants, of which one was clearly pathogenic in the subset of 106 cases with a family history of both breast and ovarian cancers [7]. This evidence concerns the gene BRCA2 and ovarian cancer.